Revenue
No reported data
COGNITION THERAPEUTICS INC (CGTX)
Price—Loading quote
Net income
2020
2021
2022
2023
2024
2025
Free cash flow
2020
2021
2022
2023
2024
Total cash / debt
CashTotal debt
2019
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Research & development | $37.2M | $41.7M | $37.2M | $30.3M | $18.6M | $12.9M |
| Operating expenses | $47.8M | $54.0M | $50.7M | $43.6M | $28.6M | $17.4M |
| Operating income | −$47.8M | −$54.0M | −$50.7M | −$43.6M | −$28.6M | −$17.4M |
| EBITDAderived | −$47.8M | −$53.9M | −$50.6M | −$43.5M | −$28.5M | −$17.3M |
| Net income | −$23.5M | −$34.0M | −$25.8M | −$21.4M | −$11.7M | −$7.8M |
| Basic EPSper diluted share | -$0.32 | -$0.86 | -$0.86 | -$0.91 | -$3.13 | -$23.76 |
| Diluted EPSper diluted share | -$0.32 | -$0.86 | -$0.86 | -$0.91 | -$3.13 | -$23.76 |
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Apr 16, 2026Form 4 | Doyle John BrendanChief Financial Officer | BuyCommon Stock | 10.0K | $1.13 | $11.3K | 627.5K |
| Apr 16, 2026Form 4 | Ricciardi LisaCEO & President | BuyCommon Stock | 9.2K | $1.10 | $10.1K | 1.72M |
| Apr 16, 2026Form 4 | Caggiano AnthonyChief Medical Officer | BuyCommon Stock | 10.0K | $1.11 | $11.1K | 874.9K |
| Jan 31, 2025Form 4 | Ricciardi LisaCEO & President | BuyCommon Stock · indirect | 38.9K | $0.77 | $29.9K | 38.9K |